Harmony Biosciences Holdings (HRMY) Other Operating Expenses (2019 - 2026)

Harmony Biosciences Holdings has disclosed Other Operating Expenses across 8 years of filings, most recently posting $31.7 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $31.7 million, up 3.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $155.7 million (up 36.07% YoY), and the FY2025 annual result was $119.5 million, up 7.75% from the prior year.
• Other Operating Expenses came in at $31.7 million for Q1 2026 at Harmony Biosciences Holdings, up from $29.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $65.2 million in Q2 2025 to a low of $17.6 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $27.2 million (2024), against an average of $27.9 million.
• Across the five-year window, Other Operating Expenses increased 2.66% in 2024 and jumped 128.83% in 2025, its largest moves.
• Harmony Biosciences Holdings' Other Operating Expenses stood at $21.1 million in 2022, then grew by 27.57% to $26.9 million in 2023, then grew by 2.66% to $27.6 million in 2024, then gained by 5.72% to $29.2 million in 2025, then grew by 8.62% to $31.7 million in 2026.
• The last three Other Operating Expenses figures came in at $31.7 million (Q1 2026), $29.2 million (Q4 2025), and $29.5 million (Q3 2025), per Business Quant data.